Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1996 Apr;9(2):126–134. doi: 10.1128/cmr.9.2.126

SCID mice and the study of parasitic disease.

K B Seydel 1, S L Stanley Jr 1
PMCID: PMC172886  PMID: 8964031

Full Text

The Full Text of this article is available as a PDF (234.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham D., Eberhard M. L., Lange A. M., Yutanawiboonchai W., Perler F. B., Lok J. B. Identification of surrogate rodent hosts for larval Onchocerca lienalis and induction of protective immunity in a model system. J Parasitol. 1992 Jun;78(3):447–453. [PubMed] [Google Scholar]
  2. Amiri P., Locksley R. M., Parslow T. G., Sadick M., Rector E., Ritter D., McKerrow J. H. Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature. 1992 Apr 16;356(6370):604–607. doi: 10.1038/356604a0. [DOI] [PubMed] [Google Scholar]
  3. Anaya-Velázquez F., Martínez-Palomo A., Tsutsumi V., González-Robles A. Intestinal invasive amebiasis: an experimental model in rodents using axenic or monoxenic strains of Entamoeba histolytica. Am J Trop Med Hyg. 1985 Jul;34(4):723–730. doi: 10.4269/ajtmh.1985.34.723. [DOI] [PubMed] [Google Scholar]
  4. Ash L. R., Riley J. M. Development of subperiodic Brugia malayi in the jird, Meriones unguiculatus, with notes on infections in other rodents. J Parasitol. 1970 Oct;56(5):969–973. [PubMed] [Google Scholar]
  5. Badell E., Pasquetto V., Eling W., Thomas A., Druilhe P. Human Plasmodium liver stages in SCID mice: a feasible model? Parasitol Today. 1995 May;11(5):169–171. doi: 10.1016/0169-4758(95)80147-2. [DOI] [PubMed] [Google Scholar]
  6. Bancroft G. J., Bosma M. J., Bosma G. C., Unanue E. R. Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism. J Immunol. 1986 Jul 1;137(1):4–9. [PubMed] [Google Scholar]
  7. Bancroft G. J., Schreiber R. D., Bosma G. C., Bosma M. J., Unanue E. R. A T cell-independent mechanism of macrophage activation by interferon-gamma. J Immunol. 1987 Aug 15;139(4):1104–1107. [PubMed] [Google Scholar]
  8. Bancroft G. J., Schreiber R. D., Unanue E. R. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev. 1991 Dec;124:5–24. doi: 10.1111/j.1600-065x.1991.tb00613.x. [DOI] [PubMed] [Google Scholar]
  9. Bancroft G. J., Sheehan K. C., Schreiber R. D., Unanue E. R. Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J Immunol. 1989 Jul 1;143(1):127–130. [PubMed] [Google Scholar]
  10. Beaman M. H., Araujo F. G., Remington J. S. Protective reconstitution of the SCID mouse against reactivation of toxoplasmic encephalitis. J Infect Dis. 1994 Feb;169(2):375–383. doi: 10.1093/infdis/169.2.375. [DOI] [PubMed] [Google Scholar]
  11. Belosevic M., Finbloom D. S., Van Der Meide P. H., Slayter M. V., Nacy C. A. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J Immunol. 1989 Jul 1;143(1):266–274. [PubMed] [Google Scholar]
  12. Bosma G. C., Custer R. P., Bosma M. J. A severe combined immunodeficiency mutation in the mouse. Nature. 1983 Feb 10;301(5900):527–530. doi: 10.1038/301527a0. [DOI] [PubMed] [Google Scholar]
  13. Bosma G. C., Davisson M. T., Ruetsch N. R., Sweet H. O., Shultz L. D., Bosma M. J. The mouse mutation severe combined immune deficiency (scid) is on chromosome 16. Immunogenetics. 1989;29(1):54–57. doi: 10.1007/BF02341614. [DOI] [PubMed] [Google Scholar]
  14. Bosma G. C., Fried M., Custer R. P., Carroll A., Gibson D. M., Bosma M. J. Evidence of functional lymphocytes in some (leaky) scid mice. J Exp Med. 1988 Mar 1;167(3):1016–1033. doi: 10.1084/jem.167.3.1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Butcher G. A., Couchman A. F., Van Pelt J. F., Fleck S. L., Sinden R. E. The SCID mouse as a laboratory model for development of the exoerythrocytic stages of human and rodent malaria. Exp Parasitol. 1993 Sep;77(2):257–260. doi: 10.1006/expr.1993.1083. [DOI] [PubMed] [Google Scholar]
  16. Carroll A. M., Hardy R. R., Bosma M. J. Occurrence of mature B (IgM+, B220+) and T (CD3+) lymphocytes in scid mice. J Immunol. 1989 Aug 15;143(4):1087–1093. [PubMed] [Google Scholar]
  17. Cavacini L. A., Long C. A., Weidanz W. P. T-cell immunity in murine malaria: adoptive transfer of resistance to Plasmodium chabaudi adami in nude mice with splenic T cells. Infect Immun. 1986 Jun;52(3):637–643. doi: 10.1128/iai.52.3.637-643.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chen W., Harp J. A., Harmsen A. G., Havell E. A. Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice. Infect Immun. 1993 Aug;61(8):3548–3551. doi: 10.1128/iai.61.8.3548-3551.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chu E. T., Rosenwasser L. J., Dinarello C. A., Rosen F. S., Geha R. S. Immunodeficiency with defective T-cell response to interleukin 1. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4945–4949. doi: 10.1073/pnas.81.15.4945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Cieslak P. R., Virgin H. W., 4th, Stanley S. L., Jr A severe combined immunodeficient (SCID) mouse model for infection with Entamoeba histolytica. J Exp Med. 1992 Dec 1;176(6):1605–1609. doi: 10.1084/jem.176.6.1605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Czuprynski C. J., Brown J. F., Maroushek N., Wagner R. D., Steinberg H. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol. 1994 Feb 15;152(4):1836–1846. [PubMed] [Google Scholar]
  22. Danska J. S., Pflumio F., Williams C. J., Huner O., Dick J. E., Guidos C. J. Rescue of T cell-specific V(D)J recombination in SCID mice by DNA-damaging agents. Science. 1994 Oct 21;266(5184):450–455. doi: 10.1126/science.7524150. [DOI] [PubMed] [Google Scholar]
  23. Denkers E. Y., Gazzinelli R. T., Martin D., Sher A. Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J Exp Med. 1993 Nov 1;178(5):1465–1472. doi: 10.1084/jem.178.5.1465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Donjon C. M., Morkowski H., Cheung R. K., Leeder J. S., Dosch H. M. Reversion of the SCID phenotype by human T cell grafts. Development of cross-species immunocompetence. J Immunol. 1993 Dec 1;151(11):5948–5954. [PubMed] [Google Scholar]
  25. Fulop G. M., Phillips R. A. The scid mutation in mice causes a general defect in DNA repair. Nature. 1990 Oct 4;347(6292):479–482. doi: 10.1038/347479a0. [DOI] [PubMed] [Google Scholar]
  26. GLANZMANN E., RINIKER P. Essentielle Lymphocytophthise; ein neues Krankheitsbild aus der Säuglingspathologie. Ann Paediatr. 1950 Jul-Aug;175(1-2):1–32. [PubMed] [Google Scholar]
  27. Gazzinelli R. T., Wysocka M., Hayashi S., Denkers E. Y., Hieny S., Caspar P., Trinchieri G., Sher A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol. 1994 Sep 15;153(6):2533–2543. [PubMed] [Google Scholar]
  28. Gellin B. G., Soave R. Coccidian infections in AIDS. Toxoplasmosis, cryptosporidiosis, and isosporiasis. Med Clin North Am. 1992 Jan;76(1):205–234. doi: 10.1016/s0025-7125(16)30377-7. [DOI] [PubMed] [Google Scholar]
  29. Giblett E. R., Ammann A. J., Wara D. W., Sandman R., Diamond L. K. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet. 1975 May 3;1(7914):1010–1013. doi: 10.1016/s0140-6736(75)91950-9. [DOI] [PubMed] [Google Scholar]
  30. Giblett E. R., Anderson J. E., Cohen F., Pollara B., Meuwissen H. J. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet. 1972 Nov 18;2(7786):1067–1069. doi: 10.1016/s0140-6736(72)92345-8. [DOI] [PubMed] [Google Scholar]
  31. Gibson D. M., Bosma G. C., Bosma M. J. Limited clonal diversity of serum immunoglobulin in leaky scid mice. Curr Top Microbiol Immunol. 1989;152:125–136. doi: 10.1007/978-3-642-74974-2_16. [DOI] [PubMed] [Google Scholar]
  32. Grun J. L., Weidanz W. P. Immunity to Plasmodium chabaudi adami in the B-cell-deficient mouse. Nature. 1981 Mar 12;290(5802):143–145. doi: 10.1038/290143a0. [DOI] [PubMed] [Google Scholar]
  33. Hagiwara K., Tsuji M., Ishihara C., Tajima M., Kurosawa T., Iwai H., Takahashi K. Theileria sergenti infection in the Bo-RBC-SCID mouse model. Parasitol Res. 1993;79(6):466–470. doi: 10.1007/BF00931584. [DOI] [PubMed] [Google Scholar]
  34. Harp J. A., Chen W., Harmsen A. G. Resistance of severe combined immunodeficient mice to infection with Cryptosporidium parvum: the importance of intestinal microflora. Infect Immun. 1992 Sep;60(9):3509–3512. doi: 10.1128/iai.60.9.3509-3512.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Havran W. L., Boismenu R. Activation and function of gamma delta T cells. Curr Opin Immunol. 1994 Jun;6(3):442–446. doi: 10.1016/0952-7915(94)90125-2. [DOI] [PubMed] [Google Scholar]
  36. Heinzel F. P., Sadick M. D., Holaday B. J., Coffman R. L., Locksley R. M. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med. 1989 Jan 1;169(1):59–72. doi: 10.1084/jem.169.1.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Hines S. A., Crandall R. B., Crandall C. A., Thompson J. P. Lymphatic filariasis. Brugia malayi infection in the ferret (Mustela putorius furo). Am J Pathol. 1989 Jun;134(6):1373–1376. [PMC free article] [PubMed] [Google Scholar]
  38. Holaday B. J., Sadick M. D., Wang Z. E., Reiner S. L., Heinzel F. P., Parslow T. G., Locksley R. M. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J Immunol. 1991 Sep 1;147(5):1653–1658. [PubMed] [Google Scholar]
  39. Hsieh C. S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 1993 Apr 23;260(5107):547–549. doi: 10.1126/science.8097338. [DOI] [PubMed] [Google Scholar]
  40. Ifversen P., Mårtensson C., Danielsson L., Ingvar C., Carlsson R., Borrebaeck C. A. Induction of primary antigen-specific immune reponses in SCID-hu-PBL by coupled T-B epitopes. Immunology. 1995 Jan;84(1):111–116. [PMC free article] [PubMed] [Google Scholar]
  41. Johnson L. L. SCID mouse models of acute and relapsing chronic Toxoplasma gondii infections. Infect Immun. 1992 Sep;60(9):3719–3724. doi: 10.1128/iai.60.9.3719-3724.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Kearney J. F., Solvason N., Stohrer R., Ma J., Van Cleave V., Leheun A., Fulop G., Fried M. Pauciclonal B cell involvement in production of immunoglobulin in scid Ig+ mice. Curr Top Microbiol Immunol. 1989;152:137–147. doi: 10.1007/978-3-642-74974-2_17. [DOI] [PubMed] [Google Scholar]
  43. Keene W. E., Hidalgo M. E., Orozco E., McKerrow J. H. Entamoeba histolytica: correlation of the cytopathic effect of virulent trophozoites with secretion of a cysteine proteinase. Exp Parasitol. 1990 Aug;71(2):199–206. doi: 10.1016/0014-4894(90)90022-5. [DOI] [PubMed] [Google Scholar]
  44. Khan I. A., Matsuura T., Kasper L. H. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun. 1994 May;62(5):1639–1642. doi: 10.1128/iai.62.5.1639-1642.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Kirchgessner C. U., Patil C. K., Evans J. W., Cuomo C. A., Fried L. M., Carter T., Oettinger M. A., Brown J. M. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science. 1995 Feb 24;267(5201):1178–1183. doi: 10.1126/science.7855601. [DOI] [PubMed] [Google Scholar]
  46. Kirchgessner C. U., Tosto L. M., Biedermann K. A., Kovacs M., Araujo D., Stanbridge E. J., Brown J. M. Complementation of the radiosensitive phenotype in severe combined immunodeficient mice by human chromosome 8. Cancer Res. 1993 Dec 15;53(24):6011–6016. [PubMed] [Google Scholar]
  47. Komatsu K., Ohta T., Jinno Y., Niikawa N., Okumura Y. Functional complementation in mouse-human radiation hybrids assigns the putative murine scid gene to the pericentric region of human chromosome 8. Hum Mol Genet. 1993 Jul;2(7):1031–1034. doi: 10.1093/hmg/2.7.1031. [DOI] [PubMed] [Google Scholar]
  48. Kresina T. F., Wisnewski A., Love-Homan L., Ramirez B., Neil G. A. Induction of hepatic pathology in SCID-Hu mice engrafted with peripheral blood lymphocytes of patients with Schistosomiasis japonica. J Infect Dis. 1994 Sep;170(3):733–736. doi: 10.1093/infdis/170.3.733. [DOI] [PubMed] [Google Scholar]
  49. Kuhls T. L., Mosier D. A., Abrams V. L., Crawford D. L., Greenfield R. A. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency. J Parasitol. 1994 Jun;80(3):480–485. [PubMed] [Google Scholar]
  50. Kurimasa A., Nagata Y., Shimizu M., Emi M., Nakamura Y., Oshimura M. A human gene that restores the DNA-repair defect in SCID mice is located on 8p11.1-->q11.1. Hum Genet. 1994 Jan;93(1):21–26. doi: 10.1007/BF00218907. [DOI] [PubMed] [Google Scholar]
  51. Leonard W. J. The defective gene in X-linked severe combined immunodeficiency encodes a shared interleukin receptor subunit: implications for cytokine pleiotropy and redundancy. Curr Opin Immunol. 1994 Aug;6(4):631–635. doi: 10.1016/0952-7915(94)90152-x. [DOI] [PubMed] [Google Scholar]
  52. Lieber M. R. The mechanism of V(D)J recombination: a balance of diversity, specificity, and stability. Cell. 1992 Sep 18;70(6):873–876. doi: 10.1016/0092-8674(92)90237-7. [DOI] [PubMed] [Google Scholar]
  53. Lisowska-Grospierre B., Charron D. J., de Préval C., Durandy A., Griscelli C., Mach B. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome. J Clin Invest. 1985 Jul;76(1):381–385. doi: 10.1172/JCI111974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Locksley R. M., Louis J. A. Immunology of leishmaniasis. Curr Opin Immunol. 1992 Aug;4(4):413–418. doi: 10.1016/s0952-7915(06)80032-4. [DOI] [PubMed] [Google Scholar]
  55. Martino G., Anastasi J., Feng J., Mc Shan C., DeGroot L., Quintans J., Grimaldi L. M. The fate of human peripheral blood lymphocytes after transplantation into SCID mice. Eur J Immunol. 1993 May;23(5):1023–1028. doi: 10.1002/eji.1830230506. [DOI] [PubMed] [Google Scholar]
  56. Mazingue C., Cottrez F., Auriault C., Cesbron J. Y., Capron A. Obtention of a human primary humoral response against schistosome protective antigens in severe combined immunodeficiency mice after the transfer of human peripheral blood mononuclear cells. Eur J Immunol. 1991 Jul;21(7):1763–1766. doi: 10.1002/eji.1830210728. [DOI] [PubMed] [Google Scholar]
  57. McCune J. M., Namikawa R., Kaneshima H., Shultz L. D., Lieberman M., Weissman I. L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988 Sep 23;241(4873):1632–1639. doi: 10.1126/science.241.4873.1632. [DOI] [PubMed] [Google Scholar]
  58. McDonald V., Deer R., Uni S., Iseki M., Bancroft G. J. Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice. Infect Immun. 1992 Aug;60(8):3325–3331. doi: 10.1128/iai.60.8.3325-3331.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Mead J. R., Arrowood M. J., Healey M. C., Sidwell R. W. Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes. J Protozool. 1991 Nov-Dec;38(6):59S–61S. [PubMed] [Google Scholar]
  60. Mead J. R., Ilksoy N., You X., Belenkaya Y., Arrowood M. J., Fallon M. T., Schinazi R. F. Infection dynamics and clinical features of cryptosporidiosis in SCID mice. Infect Immun. 1994 May;62(5):1691–1695. doi: 10.1128/iai.62.5.1691-1695.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Meding S. J., Langhorne J. CD4+ T cells and B cells are necessary for the transfer of protective immunity to Plasmodium chabaudi chabaudi. Eur J Immunol. 1991 Jun;21(6):1433–1438. doi: 10.1002/eji.1830210616. [DOI] [PubMed] [Google Scholar]
  62. Moore J. M., Kumar N., Shultz L. D., Rajan T. V. Maintenance of the human malarial parasite, Plasmodium falciparum, in scid mice and transmission of gametocytes to mosquitoes. J Exp Med. 1995 Jun 1;181(6):2265–2270. doi: 10.1084/jem.181.6.2265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Mosmann T. R., Coffman R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173. doi: 10.1146/annurev.iy.07.040189.001045. [DOI] [PubMed] [Google Scholar]
  64. Nelson F. K., Greiner D. L., Shultz L. D., Rajan T. V. The immunodeficient scid mouse as a model for human lymphatic filariasis. J Exp Med. 1991 Mar 1;173(3):659–663. doi: 10.1084/jem.173.3.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Noguchi M., Yi H., Rosenblatt H. M., Filipovich A. H., Adelstein S., Modi W. S., McBride O. W., Leonard W. J. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993 Apr 9;73(1):147–157. doi: 10.1016/0092-8674(93)90167-o. [DOI] [PubMed] [Google Scholar]
  66. Perryman L. E., Kegerris K. A., Mason P. H. Effect of orally administered monoclonal antibody on persistent Cryptosporidium parvum infection in scid mice. Infect Immun. 1993 Nov;61(11):4906–4908. doi: 10.1128/iai.61.11.4906-4908.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Perryman L. E., Mason P. H., Chrisp C. E. Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice. Infect Immun. 1994 Apr;62(4):1474–1477. doi: 10.1128/iai.62.4.1474-1477.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Rajan T. V., Nelson F. K., Cupp E., Schultz L. D., Greiner D. L. Survival of Onchocerca volvulus in nodules implanted in immunodeficient rodents. J Parasitol. 1992 Feb;78(1):160–163. [PubMed] [Google Scholar]
  69. Reed S. G., Scott P. T-cell and cytokine responses in leishmaniasis. Curr Opin Immunol. 1993 Aug;5(4):524–531. doi: 10.1016/0952-7915(93)90033-o. [DOI] [PubMed] [Google Scholar]
  70. Riggs M. W., Cama V. A., Leary H. L., Jr, Sterling C. R. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice. Infect Immun. 1994 May;62(5):1927–1939. doi: 10.1128/iai.62.5.1927-1939.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Rogers H. W., Unanue E. R. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun. 1993 Dec;61(12):5090–5096. doi: 10.1128/iai.61.12.5090-5096.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Rohlman V. C., Kuhls T. L., Mosier D. A., Crawford D. L., Greenfield R. A. Cryptosporidium parvum infection after abrogation of natural killer cell activity in normal and severe combined immunodeficiency mice. J Parasitol. 1993 Apr;79(2):295–297. [PubMed] [Google Scholar]
  73. Rosen F. S., Cooper M. D., Wedgwood R. J. The primary immunodeficiencies (1). N Engl J Med. 1984 Jul 26;311(4):235–242. doi: 10.1056/NEJM198407263110406. [DOI] [PubMed] [Google Scholar]
  74. Rosen F. S., Cooper M. D., Wedgwood R. J. The primary immunodeficiencies. (2). N Engl J Med. 1984 Aug 2;311(5):300–310. doi: 10.1056/NEJM198408023110506. [DOI] [PubMed] [Google Scholar]
  75. Sacci J. B., Jr, Schriefer M. E., Resau J. H., Wirtz R. A., Detolla L. J., Jr, Markham R. B., Azad A. F. Mouse model for exoerythrocytic stages of Plasmodium falciparum malaria parasite. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3701–3705. doi: 10.1073/pnas.89.9.3701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Sandhu J., Shpitz B., Gallinger S., Hozumi N. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J Immunol. 1994 Apr 15;152(8):3806–3813. [PubMed] [Google Scholar]
  77. Schlüter D., Deckert-Schlüter M., Schwendemann G., Brunner H., Hof H. Expression of major histocompatibility complex class II antigens and levels of interferon-gamma, tumour necrosis factor, and interleukin-6 in cerebrospinal fluid and serum in Toxoplasma gondii-infected SCID and immunocompetent C.B-17 mice. Immunology. 1993 Mar;78(3):430–435. [PMC free article] [PubMed] [Google Scholar]
  78. Schuler W., Weiler I. J., Schuler A., Phillips R. A., Rosenberg N., Mak T. W., Kearney J. F., Perry R. P., Bosma M. J. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell. 1986 Sep 26;46(7):963–972. doi: 10.1016/0092-8674(86)90695-1. [DOI] [PubMed] [Google Scholar]
  79. Scott P., Natovitz P., Coffman R. L., Pearce E., Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med. 1988 Nov 1;168(5):1675–1684. doi: 10.1084/jem.168.5.1675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Sedegah M., Finkelman F., Hoffman S. L. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10700–10702. doi: 10.1073/pnas.91.22.10700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Shankar A. H., Titus R. G. Leishmania major-specific, CD4+, major histocompatibility complex class II-restricted T cells derived in vitro from lymphoid tissues of naive mice. J Exp Med. 1993 Jul 1;178(1):101–111. doi: 10.1084/jem.178.1.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Shibayama-Salas M., Tsutsumi V., Martínez-Palomo A. Early invasive intestinal amebiasis in Mongolian gerbils. Arch Med Res. 1992;23(2):187–190. [PubMed] [Google Scholar]
  83. Stanley S. L., Jr, Zhang T., Rubin D., Li E. Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice. Infect Immun. 1995 Apr;63(4):1587–1590. doi: 10.1128/iai.63.4.1587-1590.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Tannich E., Scholze H., Nickel R., Horstmann R. D. Homologous cysteine proteinases of pathogenic and nonpathogenic Entamoeba histolytica. Differences in structure and expression. J Biol Chem. 1991 Mar 15;266(8):4798–4803. [PubMed] [Google Scholar]
  85. Touraine J. L., Betuel H., Souillet G., Jeune M. Combined immunodeficiency disease associated with absence of cell-surface HLA-A and -B antigens. J Pediatr. 1978 Jul;93(1):47–51. doi: 10.1016/s0022-3476(78)80598-8. [DOI] [PubMed] [Google Scholar]
  86. Tripp C. S., Gately M. K., Hakimi J., Ling P., Unanue E. R. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol. 1994 Feb 15;152(4):1883–1887. [PubMed] [Google Scholar]
  87. Tripp C. S., Wolf S. F., Unanue E. R. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3725–3729. doi: 10.1073/pnas.90.8.3725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Tsuji M., Hagiwara K., Takahashi K., Ishihara C., Azuma I., Siddiqui W. A. Theileria sergenti proliferates in SCID mice with bovine erythrocyte transfusion. J Parasitol. 1992 Aug;78(4):750–752. [PubMed] [Google Scholar]
  89. Varkila K., Chatelain R., Leal L. M., Coffman R. L. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Eur J Immunol. 1993 Jan;23(1):262–268. doi: 10.1002/eji.1830230141. [DOI] [PubMed] [Google Scholar]
  90. Walsh J. A. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis. 1986 Mar-Apr;8(2):228–238. doi: 10.1093/clinids/8.2.228. [DOI] [PubMed] [Google Scholar]
  91. Wherry J. C., Schreiber R. D., Unanue E. R. Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect Immun. 1991 May;59(5):1709–1715. doi: 10.1128/iai.59.5.1709-1715.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Zhang T., Cieslak P. R., Foster L., Kunz-Jenkins C., Stanley S. L., Jr Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amoebic liver abscess in severe combined immunodeficient (SCID) mice. Parasite Immunol. 1994 May;16(5):225–230. doi: 10.1111/j.1365-3024.1994.tb00344.x. [DOI] [PubMed] [Google Scholar]
  93. van der Heyde H. C., Elloso M. M., Chang W. L., Kaplan M., Manning D. D., Weidanz W. P. Gamma delta T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria. J Immunol. 1995 Apr 15;154(8):3985–3990. [PubMed] [Google Scholar]
  94. van der Heyde H. C., Huszar D., Woodhouse C., Manning D. D., Weidanz W. P. The resolution of acute malaria in a definitive model of B cell deficiency, the JHD mouse. J Immunol. 1994 May 1;152(9):4557–4562. [PubMed] [Google Scholar]
  95. van der Heyde H. C., Manning D. D., Weidanz W. P. Role of CD4+ T cells in the expansion of the CD4-, CD8- gamma delta T cell subset in the spleens of mice during blood-stage malaria. J Immunol. 1993 Dec 1;151(11):6311–6317. [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES